Value of a new four-antigen recombinant immunoblot assay in predicting recurrence of hepatitis C virus infection following liver transplantation.
Lumbreras
C
C
Infectious Diseases Section, Hospital 12 de Octubre, School of Medicine, Complutense University, Madrid, Spain.
Gimeno
C
C
Colina
F
F
Fuertes
A
A
Lizasoain
M
M
Aguado
J M
JM
Loinaz
C
C
Iglesias
J
J
Moreno
E
E
Noriega
A R
AR
D000328:Adult; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005500:Follow-Up Studies; D006508:Hepatitis Antibodies / Q000097:blood; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D018937:Hepatitis C Antibodies; D006801:Humans; D015151:Immunoblotting / Q000379:methods; D016031:Liver Transplantation / Q000473:pathology; D011379:Prognosis; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000032:analysis; D012008:Recurrence
D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D011994:Recombinant Proteins